Clinical Trials Browser

Completed × Interventional × Osteolysis × Clear all

Multiple Myeloma, Osteolysis, Osteonecrosis

NCT01447914 2019-08-28

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Classical hematologyOther hematologic neoplasmPlasma cell

Amyloidosis, Anemia, Bone Diseases, Metabolic, Fractures, Spontaneous, Hypercalcemia, Multiple Myeloma, Osteolysis, Paraproteinemias, Hematologic Neoplasms, Renal Insufficiency

Clinical Trials

Magnolia

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma